Plain-English translation of NCT05633056 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding counseling and mobile phone support programs helps people with drug-resistant TB and HIV stick with their new medications. Researchers are comparing four different types of support — from standard medical care alone to adding one-on-one counseling, mobile health tools, or both. The goal is to find the best way to help people take Bedaquiline and other new TB and HIV medicines as prescribed.
People with drug-resistant TB and HIV often struggle to take their medications consistently because the regimens are complex and side effects can be difficult. This trial is testing whether extra support — through counseling, mobile phone reminders, or both — can help people stay on their treatment and have better health outcomes.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four support groups: standard medical care, counseling sessions with a trained counselor, mobile phone-based reminders and tracking, or both counseling and mobile support. You'll have monthly in-person visits for the first six months while taking the medication, then phone check-ins through the end of your treatment (typically around 12 months). Study staff will track how well you're taking your medications and how you're doing overall.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
South Africa